Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Barbara Burtness | Researchclopedia

Back to researchers

Barbara Burtness

Yale Cancer Center ORCID

733

Works

38,504

Citations

74

h-index

258

i10-index

Research Topics

Head and Neck Cancer Studies Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers

Affiliations

Bryn Mawr College1984–1984

Northwestern University2007–2007

Hiroshima University2002–2002

University of Southern California1996–1998

Oslo University Hospital2021–2021

Top Works

Head and neck squamous cell carcinoma

Daniel E. Johnson,Barbara Burtness,et al.

20203,884 citations

Cancer Diagnosis and Treatment

Radiomics and Machine Learning in Medical Imaging

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness,Kevin J. Harrington,et al.

20193,093 citations

Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial

Tanguy Y. Seiwert,Barbara Burtness,et al.

20161,720 citations

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E.W. Cohen,Denis Soulières,et al.

20181,659 citations

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

Maura L. Gillison,Andy Trotti,et al.

20181,266 citations

Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial

Kei Muro,Hyun Cheol Chung,et al.

20161,124 citations

Phase III Randomized Trial of Cisplatin Plus Placebo Compared With Cisplatin Plus Cetuximab in Metastatic/Recurrent Head and Neck Cancer: An Eastern Cooperative Oncology Group Study

Barbara Burtness,Meredith A. Goldwasser,et al.

2005883 citations

Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort

Laura Q.M. Chow,Robert I. Haddad,et al.

2016850 citations

The changing therapeutic landscape of head and neck cancer

John D. Cramer,Barbara Burtness,et al.

2019795 citations